Clinical trials
Terminated Phase 2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 7 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Duke University | 3 |
| University of California, San Francisco | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Annick Desjardins | 1 |
| Arog Pharmaceuticals, Inc. | 1 |
| Bernardino Clavo, MD, PhD | 1 |
| Burzynski Research Institute | 1 |
| Case Comprehensive Cancer Center | 1 |
| Cellectar Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 43 |
| Glioblastoma | 30 |
| Astrocytoma | 17 |
| Brain Neoplasms | 15 |
| Oligodendroglioma | 9 |
| Gliosarcoma | 8 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Disease Progression | 2 |
| Ependymoma | 2 |
| Meningioma | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.